Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Clinical trial NCT00397293 · COMPLETED

Trial details

NCT number: NCT00397293
Sponsor: Ascenta Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2006-11-01
Primary completion: 2008-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.